CMHX008, a PPARγ partial agonist, enhances insulin sensitivity with minor influences on bone loss

Traditional thiazolidinediones (TZDs), such as rosiglitazone, are peroxisome proliferator-activated receptor γ (PPARγ) potent agonists that can be used to treat type 2 diabetes but carry unwanted effects, including increased risk for fracture. The present work aimed to compare the insulin-sensitizin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Yi, Cao, Xuemei, Hu, Xiangnan, Li, Xinyu, Shi, Xiaoqin, Wang, Hongying, Peng, Chuan, Li, Jiayu, Li, Jibin, Li, Qifu, Wu, Chaodong, Xiao, Xiaoqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176219/
https://www.ncbi.nlm.nih.gov/pubmed/30320193
http://dx.doi.org/10.1016/j.gendis.2018.05.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176219/
https://www.ncbi.nlm.nih.gov/pubmed/30320193
http://dx.doi.org/10.1016/j.gendis.2018.05.004

Ejemplares similares